Further analysis of public datasets revealed that only FOXC1 was consistently associated with poor survival of 498 (GSE62564), 283 (GSE85047), 102 (GSE3446), and 88 (GSE16476) NB patients (Fig. S1A). Here, FOXC1 is linked to neuroblastoma.